IOL Chemicals And Pharmaceuticals Ltd.

₹69.7

0.6 (0.9%)

IOLCP Share Price

Pharmaceuticals & Biotechnology

As on January 27, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 2,049 Cr

P/E Ratio20.26

Dividend Yield0.57 %

Trendline Performance

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	70.55	Bearish
10-DMA	72.92	Bearish
20-DMA	77.18	Bearish
50-DMA	82.95	Bearish
100-DMA	92.63	Bearish
200-DMA	88.96	Bearish

Historical Performance

1 Year

-3.4%

3 Years

7.3%

5 Years

-50.9%

10 Years

404%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	20,792	21,328	22,171	21,840
Total Expenditure	18,769	19,022	19,914	19,257
Other Income	224	301	256	320
Operating Profit	2,247	2,607	2,513	2,903
Interest	148	161	165	83
Depreciation	720	629	462	433
Profit Before Tax	1,380	1,816	1,886	2,249
Consolidated Net Profit	1,011	1,344	1,391	1,677
Adjusted EPS	3	5	5	6

Compounded Sales Growth

10 Years:40.1

5 Years:1.9

3 Years:-1

TTM:-0.5

Compounded Profit Growth

10 Years:-12.1

5 Years:-22.5

3 Years:-9.4

TTM:-5.7

Stock Price CAGR

10 Years:17.1

5 Years:-12.7

3 Years:2.4

TTM:-2.5

Return on Equity

10 Years:-1.4

5 Years:15.1

3 Years:4.8

last year:3.4

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	587	587	587	587
Total Reserves	16,289	15,528	14,490	13,336
Long-Term Borrowings	---	---	---	---
Total Non-Current Liabilities	845	729	582	566
Other Current Liabilities	633	547	543	540
Short Term Borrowings	1,170	328	796	428
Total Liabilities	24,107	22,815	20,684	20,242
Capital Work in Progress	208	998	814	1,020
Long Term Loans & Advances	121	236	95	108
Currents Investments	33	29	26	24
Short Term Loans and Advances	673	901	816	897
Total Current Assets	11,800	11,569	9,667	11,427
Total Assets	24,107	22,815	20,684	20,242
Adjusted Book Value	57	55	257	237

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a moderate PE of 20.26, suggesting fair valuation relative to earnings.
Over the last three years, the stock delivered a weak 3-year price CAGR of 3.3%, indicating poor shareholder returns.
The stock carries a high beta of 1.8, implying higher volatility and elevated risk.
In the last financial year, the company reported an EBITDA of ₹2246 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹20792 million, indicating a large and established business.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 974961.5

No. of Shares: 13988 (Approx)

Performance:-2.5%

P/L: ₹-25038.5

NIFTY Performance: 9.7%

1 day Top Gainers